20.62% | % of shares held by all insiders |
63.08% | % of shares held by institutions |
79.46% | % of float held by institutions |
330 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
QVT Financial LP | 112,541,536 | 31 Dec 2023 | 13.97% | 1,099,530,858 |
SB Investment Advisers (UK) LTD | 73,031,667 | 31 Dec 2023 | 9.06% | 713,519,420 |
Viking Global Investors, L.P. | 69,368,961 | 31 Dec 2023 | 8.61% | 677,734,780 |
FMR, LLC | 36,976,248 | 31 Dec 2023 | 4.59% | 361,257,959 |
Morgan Stanley | 21,927,044 | 31 Dec 2023 | 2.72% | 214,227,229 |
Blackrock Inc. | 20,805,601 | 31 Dec 2023 | 2.58% | 203,270,731 |
Rubric Capital Management LP | 19,000,000 | 31 Dec 2023 | 2.36% | 185,630,008 |
State Street Corporation | 13,727,418 | 31 Dec 2023 | 1.70% | 134,116,880 |
Wellington Management Group, LLP | 13,640,416 | 31 Dec 2023 | 1.69% | 133,266,870 |
Patient Square Capital LP | 12,639,920 | 31 Dec 2023 | 1.57% | 123,492,024 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 10,901,291 | 29 Feb 2024 | 1.35% | 106,505,618 |
iShares Core S&P Midcap ETF | 10,506,573 | 31 Mar 2024 | 1.30% | 102,649,223 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 7,192,287 | 31 Mar 2024 | 0.89% | 70,268,647 |
Vanguard Extended Market Index Fund | 4,945,664 | 31 Dec 2023 | 0.61% | 48,319,139 |
Fidelity Select Portfolios - Biotechnology | 4,387,019 | 29 Feb 2024 | 0.54% | 42,861,177 |
Morgan Stanley Inst Fd Inc-Growth Port | 4,130,061 | 31 Dec 2023 | 0.51% | 40,350,697 |
iShares Biotechnology ETF | 3,612,345 | 31 Mar 2024 | 0.45% | 35,292,612 |
Fidelity Growth Company K6 Fund | 3,492,724 | 29 Feb 2024 | 0.43% | 34,123,915 |
Fidelity Series Growth Company Fund | 2,772,000 | 29 Feb 2024 | 0.34% | 27,082,441 |
Fidelity Extended Market Index Fund | 1,863,938 | 29 Feb 2024 | 0.23% | 18,210,675 |